Investors

FINANCIAL CALENDAR
2025-06-27 – Annual General Meeting of the Shareholders (AGM)
2025-06-10 – Statutory financial statements and the auditor’s report
2025-05-20 – Interim Report 2025 – Q1

Discover more at Spotlight Stock Market
——————-
FINANCIAL REPORTS
2025
2025 – Q1 – Interim Report
2024
2024 – Q4 – Interim Report
2024 – Q3 – Interim Report
2024 – Q2 – Interim Report
2024 – Q1 – Interim Report
2023
2023 – Year End Report
——————-
PRESS RELEASES
Archive for press releases

2025-05-13
New sales orders across key markets
2025-05-13
HALAL certification unlocks new market opportunities
2025-06-12
Relocation of the production to Norway
2025-06-12
Warns of strained liquidity and delayed audit
2025-05-23
Successful tradeshow and product launch
2025-05-23
Five-Year Supply Agreement
2025-05-20
Interim Report Q1 – 2025
2025-05-16
Adjustments to the Financial calendar
2025-05-14
High-strength organic Aronia extract at Vitafoods 2025
2025-05-09
Strategic North American Partnership
2025-05-07
Order from U.S. Partner
2025-05-06
Tariff driven supply chain uncertainty brings in requests
2025-05-06
New sales orders across key markets
2025-05-02
Notice of extraordinary general meeting
2025-05-02
Grant of warrants
2025-04-28
Launching a new health Ingredient
2025-04-01
Good Start to Q2-25 with new sales order
2025-03-06
Repeat sales order with potential upside
2025-03-03
Sales order for premium organic elderberry extract
2025-02-28
Last day of trading in paid subscribed shares
2025-02-26
Sensing stronger demand for high-quality bilberry extracts
2025-02-25
Flagging announcement
2025-02-13
Equipment and berry product divestment transaction
2025-02-12
Flagging of share purchase by Stein Ulve
2025-02-12
A new stage in global sales project
2025-02-11
Sales orders for KSEK 619
2025-02-10
Participation at Biofach – the world’s leading organic fair
2025-02-07
Costs will decrease after cooperation negotiations
2025-02-06
Invitation to investor webinars
2025-02-06
Interim Report Q4 – 2024
2025-02-05
Collaboration with forest owners
2025-02-05
Divesting eye-health lead candidate intellectual property
2025-02-04
Publication of the Q4 2024 Interim Report and ongoing rights issue
2025-01-30
Invitation to investor webinars
2025-01-29
New orders and a customer
2025-01-28
Investment teaser
2025-01-28
New orders and a customer
2025-01-28
The subscription period for the rights issue of shares commences
2025-01-27
Exemption document regarding rights issue
2025-01-27
Marinus Blåbjerg Sørensen elected as new Board Member
2025-01-24
Sales Order for 638 KSEK
2025-01-23
Sales Order for 1,2 MSEK
2025-01-23
New online distribution channel for selected products
2025-01-17
Notice Rights Issue
2025-01-17
Communique EGM January
2025-01-17
Notice to the Extraordinary General Meeting
2024-11-29
Interim Report Q3 – 2024
2024-11-04
Notice to the EGM 04 11 2024
2024-08-21
Interim Report Q2 – 2024
2024-07-11
The outcome of the rights issue
2024-06-28
Communique from the AGM 28 06 2024
2024-05-20
Restated Interim report Q1 – 2024
2024-05-10
Notice of the AGM 28 06 2024

Archive for press releases
——————-
OTHER DOCUMENTS
Exemption document
2025-01 – Investment teaser
——————-
CONTACT FOR INVESTORS
Stein Ulve
CEO
Tel. +358 400 22 5967
stein.ulve@eeviahealth.com
——————-

THE BOARD OF DIRECTORS
Terry Virts | Chairman
Diane E. Clayton | Member
Marinus Blåbjerg Sørensen | Member
Oskar Wegelius | Member
Per Benjaminse | Member
Stein Ulve | CEO